Bill

BILL • US SENATE

S 2870

Fight Illicit Pill Presses Act

119th Congress
Introduced by Marsha Blackburn, Maria Cantwell, Chris Coons and 6 other co-sponsors

The Fight Illicit Pill Presses Act strengthens regulations and penalties to combat counterfeit medications, enhancing public safety and supporting law enforcement efforts.

Introduced in Senate
0
0
Bill Summary • S 2870

Summary of Bill S 2870: Fight Illicit Pill Presses Act

Bill Number: S 2870

Introduced: September 18, 2025

Status: Introduced in Senate

Classification: Bill

Purpose and Intent

The Fight Illicit Pill Presses Act aims to combat the growing issue of illicit pill presses that are used to manufacture counterfeit prescription medications. These counterfeit drugs pose significant health risks to the public and contribute to the ongoing opioid crisis. The bill seeks to enhance regulatory measures and enforcement capabilities to prevent the production and distribution of these dangerous substances.

Key Provisions

The bill includes several important provisions designed to address the issue of illicit pill presses:

  • Regulatory Framework: Establishes a regulatory framework for the registration and oversight of pill presses, requiring manufacturers and distributors to comply with strict guidelines.

  • Penalties for Violations: Introduces increased penalties for individuals and entities found to be operating unregistered pill presses or distributing counterfeit medications. This includes both civil and criminal penalties.

  • Law Enforcement Support: Provides resources and support to law enforcement agencies to enhance their ability to detect and dismantle illegal pill press operations.

  • Public Awareness Campaigns: Mandates the development of public awareness campaigns to educate the public about the dangers of counterfeit medications and how to identify them.

Who Would Be Affected

The Fight Illicit Pill Presses Act would primarily affect:

  • Manufacturers and Distributors: Entities involved in the production and distribution of pharmaceutical products would need to comply with new regulations and oversight measures.

  • Law Enforcement Agencies: Local, state, and federal law enforcement agencies would receive additional resources to combat illicit operations.

  • Public Health: The general public would benefit from increased safety and reduced risk of exposure to counterfeit medications.

Procedural Aspects

  • Legislative Actions:

    • The bill was introduced in the Senate on September 18, 2025.
    • It was read twice and referred to the Committee on the Judiciary on the same day.
  • Sponsors: The bill is sponsored by Senator John Cornyn and has several cosponsors, including:

    • Jerry Moran
    • Ruben Gallego
    • Amy Klobuchar
    • Thomas Roland Tillis
    • Christopher A. Coons
    • David H. McCormick

Conclusion

The Fight Illicit Pill Presses Act represents a proactive approach to tackling the serious issue of counterfeit medications and the illicit production of pills. By establishing a regulatory framework and enhancing law enforcement capabilities, the bill aims to protect public health and safety from the dangers posed by these illegal operations. As it moves through the legislative process, further discussions and amendments may shape its final form and impact.

Hi! I'm your AI assistant for S 2870. I can help you understand its provisions, impacts, and answer any questions.

Key Provisions Impacts Timeline
Sign in to chat